论"兼化"OA

Discussion on'Jianhua'

中文摘要英文摘要

"兼化"最早由金元医家刘完素提出,是中医学原创概念,也是诸多疾病发生发展过程中的共性病机."兼化"有相兼所现之变化、兼并之转化等多种含义.其中,相兼所现之变化由本气亢盛引起,主要包括同性相兼、异性相兼、承制相兼三种类型,治宜"泻其过甚之气";兼并之转化由本气不及引起,指本气不及之时,被其不胜之气兼并同化的现象,治宜补益不及之本气,兼顾兼化、齐化之气.病机兼化是当代对于传统兼化理论的进一步创新发挥,强调在基本病机之下,该疾病发生发展全过程中所发生的兼夹病机转化规律.兼化理论的传承与创新应用,有望对中医药解决当代各类难治复杂病机疾病的诊疗思路有所有启示,切实提升临床疗效.

'Jianhua'was first proposed by LIU Wansu,a doctor in the Jin and Yuan dynasties.It is an original concept of traditional Chinese medicine and a common pathogenesis in the occurrence and development of many diseases.'Jianhua'has many meanings,such as the changes arising from mutual concurrence and transformation through annexation.Among them,the changes arising from mutual concurrence are caused by the hyperactivity of the original qi,which mainly includes three types:the same phase,the different phase,and the restriction and control.The treatment should be'purging the excessive qi';Transformation via mutual assimilation of qi is caused by the lack of capital qi.It refers to the phenomenon that when the capital qi is less than the capital gas,it is merged and assimilated by the gas that is less than the capital qi.It is advisable to treat and supplement the qi that is less than the capital qi,and give consideration to the qi of both concurrent and coordinated transformation.Concurrent pathogenesis is a further innovation of the traditional theory of Jianhua,emphasizing the transformation patterns of concurrent pathogenesis in the whole process of the occurrence and development of the disease under the basic pathogenesis.The inheritance and innovative application of the Jianhua theory is expected to enlighten the diagnosis and treatment ideas for solving all kinds of refractory and complex diseases in contemporary Chinese medicine,and effectively improve the clinical efficacy.

汪锦城;胡镜清

南京中医药大学中医药文献研究院,南京 210023||中国中医科学院中医基础理论研究所,北京 100700中国中医科学院中医基础理论研究所,北京 100700||天津中医药大学中医学院,天津 301617

兼化病机五运六气中医基础理论

JianhuaPathogenesisFive circuits and six qiBasic theory of traditional Chinese medicine

《中华中医药杂志》 2026 (9)

2406-2410,5

国家重点研发计划(No.2019YFC1708501),天津市顶尖科学家项目(No.25JRRCRC00010)

评论